Washington Research Foundation

Washington Research Foundation provides $600,000 to support research by clinician-scientists at University of Washington; with Sam Emerson, Juliane Gust, Rebecca Hendrickson and Monica Sanchez-Contreras https://lnkd.in/gHhGwa_A

Washington Research Foundation awards $6 million in research grants; via Candid https://lnkd.in/guFxQfUC

Congratulations, Shannon! We're proud to support the outstanding work you're doing.

🎙️ Sometimes, the biggest medical breakthroughs come from the most unexpected places. In the latest episode of PNRI Science: Mystery & Discovery, PNRI CEO Jack Faris talks with Dr. Aimée Dudley about how her lab uses yeast—the same yeast we use for baking bread—to uncover genetic variants responsible for rare diseases. This surprising approach is helping physicians diagnose critically ill newborns with life-threatening conditions like urea cycle disorders. Listen now to discover how unexpected tools, creative science, and collaboration between scientists, doctors, and families are transforming healthcare—no PhD required! 🔬✨ Now available on: Apple Podcasts: https://ow.ly/kva450TH9ml Spotify: https://ow.ly/FaY650TH9mi YouTube: https://ow.ly/hsEY50TH9mx Amazon: https://ow.ly/w9Aw50TH9mm #ureacycledisorder #ureacycle #rarediseaseresearch #raredisease #yeastgenetics #sciencepodcast

The $45 million Invent@SC Postdoctoral Scholars Program seeks to train the next generation of early career scientists from backgrounds historically underrepresented in or excluded from biotech.    Invent@SC scholars may choose lab mentors from Seattle Children’s, University of Washington, Fred Hutchinson Cancer Center, and Benaroya Research Institute. World renowned biotech leaders and clinicians will serve as co-mentors. The Scholars will also complete relevant coursework and participate in development activities that will further equip them for the business side of biotechnology. Candidates may apply up to six months prior to PhD degree completion.    Scholars accepted into the program will receive:   ·      starting salary of $70k+ per year for 3 years with potential for years 4-5  ·      full employment benefits  ·      $10k for professional development   ·      up to $10k for relocation expenses      Those who are interested may fill out an interest form at the QR code below to be invited to an info session and offered an opportunity to apply.

Reviews start on Friday, so please apply for our Investment Associate role ASAP. It's a great opportunity to join our small and established team.

Wearable cameras allow AI to detect medication errors; UW Medicine via EurekAlert! Featuring Kelly Michaelsen and Shyam Gollakota https://lnkd.in/g4T_zVh2

🚀 Exciting News from Kayothera! 🧬💊 We're excited to announce the expansion of our Scientific Advisory Board to advance our mission of developing groundbreaking therapies: Chaired by Yibin Kang, PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology at the Ludwig Institute of Princeton University, members include:  🧬Domenico Accili, MD, Professor of Medicine at Columbia University and the Director of the Columbia University Diabetes Research Center. Dr. Accili is the 2017 Banting Medal Recipient and is highly recognized for his pioneering work on beta cell failure in type 2 diabetes and the treatment of type 1 diabetes through enteroendocrine cell conversion; 🧬Shridar Ganesan, PhD/MD, a prominent physician-scientist and medical oncologist at the NYU Perlmutter Cancer Center, where he serves as the Director for the Center for Molecular Oncology and Professor of Medicine; 🧬Suzanne George, MD, a renowned clinical expert in sarcoma, serving as the clinical director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute and an associate professor of Medicine at Harvard Medical School; and 🧬Kendall Mohler, PhD, was previously co-founder and chief scientific officer at Trubion Pharmaceuticals, the founding CSO at Juno Therapeutics, Inc. Therapeutics, and a senior leader at Immunex, where he played a key role in the development of Enbrel (etanercept). This SAB will provide crucial insights as we develop our first-in-class, oral, small-molecule retinoid nuclear receptor pathway inhibitors. #ScientificAdvisoryBoard #BiotechLeaders #LifeSciences

Washington Research Foundation awards $6 million in grants to Fred Hutch and Seattle Children's; with Soheil Meshinchi MD., Ph.D., Aude Chapuis and David Rawlings https://lnkd.in/dc6wgB32